Survival of breast cancer patients with meningeal carcinomatosis

Annals of Oncology

Volumn 21, Issue 11, 2010, Pages 2183-2187

  Gauthier, H ^a   Guilhaume, M N ^a   Bidard, F C ^a   Pierga, J Y ^a,b   Girre, V ^a   Cottu, P H ^a   Laurence, V ^a   Livartowski, A ^a   Mignot, L ^a   Dieras V ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Breast cancer; Curie score; Intrathecal methotrexate; Meningeal carcinomatosis; Neoplastic meningitis

Indexed keywords

FLUOROURACIL; FOLINIC ACID; HORMONE RECEPTOR; HYDROCORTISONE ACETATE; METHOTREXATE; THIOTEPA;

ADULT; AGED; ARACHNOIDITIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; DRUG MEGADOSE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TREATMENT RESPONSE;

EID: 77958500804     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq232     Document Type: Article

References (17)

1. De Angelis LM, Rogers LR, Foley KM. Leptomeningeal metastasis. In Harris JR, Lippman ME, Morrow M, Osborne CK (eds): Diseases of the Breast, 2nd edition. Philadelphia, PA: Lippincott Wiliams & Wilkins 2000.
2. Chamberlain MC. Neoplastic meningitis. Oncologist 2008; 13: 967-977.
3. Rudnicka H, Niwinska A, Murawska M. Breast cancer leptomeningeal metastasis: the role of multimodality treatment. J neurooncol 2007; 84: 57-62.
4. Fizazi K, Asselain B, Vincent-Salomon A et al. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of high-dose intrathecal methotrexate regimen. Cancer 1996; 77: 1315-1323.
5. Tokuhashi Y, Matsuzaki H, Toriyama S et al. Scoring system for the preoperative evaluation of metastatic tumor prognosis. Spine 1990; 15(11): 1110-1113.
6. Jayson GC, Howell A, Harris M et al. Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant. Cancer 1994; 74: 3135-3141.
7. Boogerd W, Hart AAM, Van der Sande JJ et al. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 1991; 67: 1685-1695.
8. Clamon G, Doebbeling B. Meningeal carcinomatosis from breast cancer: spinal cord versus brain involvement. Breast Cancer Res Treat 1987; 9: 213-217.
9. Kokkoris CP. Leptomeningeal carcinomatosis: how does cancer reach the piaarachnoid? Cancer 1983; 51: 154-160.
10. Bidard FC, Guilhaume MN, Gauthier H. Meningeal carcinomatosis in HER2-overexpressing breast cancers. J Neurooncol 2009; 83: 287-288.
11. Grossman SA, Finkelstein DM, Ruckdeschel JC et al. Randomized prospective comparison of intraventrical methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol 1993; 11: 561-569.
12. Chamberlain MC. Neoplastic meningitis. J Clin Oncol 2005; 23: 3605-3613.
13. Kim DY, Lee KW, Yun T et al. Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methtrexate in combination with cytosine arabinoside and hydrocortisone. Jpn J Clin Oncol 2003; 33: 608-612.
14. Grant R, Naylor B, Greenberg HS et al. Clinical outcome in aggressively treated meningeal carcinomatosis. Arch Neurol 1994; 51: 457-461.
15. Hitchins RN, Bell DR, Woods RL et al. A prospective randomized trial of single agent versus combination chemotherapy in meningeal carcinomatosis 1987.
16. Yap H, Yap B, Rasmussen S et al. Treatment for meningeal carcinomatosis on breast cancer. Cancer 1982; 49: 219-222.
17. Klee GG, Tallman RD, Goellner JR et al. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc 1986; 61(1): 9-13.